Insurance Denial Puts Boynton Beach Patient at Risk After DVT

Boca Raton, FL – In a concerning case highlighting systemic issues within healthcare, a Boynton Beach resident was unable to secure their full, prescribed dosage of life-saving medication due to an insurance denial, following a diagnosis of deep vein thrombosis (DVT). The case underscores the sometimes devastating consequences of insurance company decisions on patient health outcomes.

The Patient's Situation

After being diagnosed with DVT — a potentially life-threatening condition in which blood clots form in deep veins, typically in the legs — the patient was prescribed anticoagulation medication at a specific dosage determined by their treating physician. However, the patient's insurance company denied coverage for the prescribed dosage, offering to cover only a lower dose that the physician deemed clinically insufficient.

DVT carries serious risks including pulmonary embolism, where a clot breaks free and travels to the lungs, which can be fatal. Adequate anticoagulation is critical to preventing this outcome, and underdosing can leave patients dangerously unprotected.

The Insurance Denial Problem

This case is far from isolated. Insurance denials for prescribed medications and treatments have become increasingly common, with insurance companies frequently overriding physician clinical judgment through prior authorization requirements, step therapy protocols, and formulary restrictions.

"When an insurance company — staffed by people who have never examined my patient — overrides my clinical decision about medication dosing, they are practicing medicine without a license," said the patient's treating physician. "And in cases like DVT, the consequences of underdosing can be fatal."

Patient Rights and Resources

Patients who receive insurance denials for prescribed medications have the right to appeal. Florida law provides specific protections for patients facing denials of medically necessary treatments. Patients can also contact the Florida Office of Insurance Regulation to file complaints about unreasonable denials.

Healthcare advocates encourage patients to work with their physicians to submit detailed appeals that include clinical documentation supporting the prescribed treatment, and to seek assistance from patient advocacy organizations when navigating the appeals process.